Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

December 18, 2021

Pregnancy Poses Challenges to MS Management, Review Study Shows

  • MS Research Study and Reports
    /
  Women with multiple sclerosis (MS) who receive high-efficacy disease-modifying therapies (DMTs) before conception have a greater risk of relapses and disability progression during…
MS Research Study and Reports

December 18, 2021

Study: Anti-CD20 Therapies, Gilenya Lower Efficacy of COVID-19 Vaccines

  • #COVID-19
    /
  • MS Drug Therapies
    /
  Certain treatments for multiple sclerosis (MS) — specifically, anti-CD20 antibody therapies and Gilenya (fingolimod) — are likely to reduce the effectiveness of vaccines…
#COVID-19

December 18, 2021

Researchers explore efficacy of methylphenidate for mental fatigue in multiple sclerosis

  • MS Research Study and Reports
    /
 By Kessler Foundation Credit: CCO Public Domain A team of researchers at Kessler Foundation studied the effects of methylphenidate on…
MS Research Study and Reports

December 18, 2021

Insomnia in Multiple Sclerosis

  • Multiple Sclerosis (MS) Symptoms
    /
 Insomnia is a common symptom of multiple sclerosis (MS), one that can significantly interfere with your quality of life by contributing…
Multiple Sclerosis (MS) Symptoms

December 17, 2021

Making a difference for the MS Community ….

  • FUNDRAISING
    /
  • MS Views and News
    /
  • Multiple Sclerosis
    /
  ____________________________________                                        …
FUNDRAISING

December 16, 2021

Health Inequities in Access to Care for Multiple Sclerosis and Related Disorders Here’s What’s Known and What’s Left to Learn

  • Access to Care
    /
  • Accessibility
    /
  • Diversity & Inclusion
    /
  • Multiple Sclerosis
    /
 By Gina Shaw – December 16, 2021 Article In Brief A review found a paucity of studies that look in depth…
Access to Care

December 15, 2021

TG Therapeutics Announces FDA Acceptance of Biologics License Application for Ublituximab as a Treatment for Patients with Relapsing Forms of Multiple Sclerosis

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
 December 14, 2021 (Globe Newswire) Prescription Drug User Fee Act (PDUFA) goal date of September 28, 2022 TG Therapeutics, Inc.…
MS Drug Therapies

December 14, 2021

COVID-19 Vaccine Reactions in People with MS Similar to General Population, Says New Society-Funded Study

  • #COVID-19
    /
  • MS Research Study and Reports
    /
 November 17, 2021 Surveys of hundreds of people with MS enrolled in the iConquerMS network reveal that reactions to COVID-19…
#COVID-19

December 14, 2021

Researchers Identify Subset of Immune Cells Driving MS

  • MS Research Study and Reports
    /
 by Marta Figueiredo PhD | December 10, 2021 A new subset of type 3 innate lymphoid cells (ILC3s) — a…
MS Research Study and Reports

December 13, 2021

Monday Mantras with Megan

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
“Monday Mantras with Megan is a weekly online mindfulness series that begins January 3, 2022 (or any time thereafter).  …
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

Categories

Latest Blog Posts